About Ceterix
Ceterix is a company based in Menlo Park (United States) founded in 2010 was acquired by Smith & Nephew in December 2018.. Ceterix has raised $73.88 million across 4 funding rounds from investors including SVB, Smith & Nephew and Oxford Finance. The company has 63 employees as of December 31, 2018. Ceterix offers products and services including OxiSelect™ Assay Kits, Antibodies, Recombinant Proteins, and Cell Culture Reagents. Ceterix operates in a competitive market with competitors including SentreHEART, Tepha, SuturTek Incorporated, Planatome and Gordian Surgical, among others.
- Headquarter Menlo Park, United States
- Employees 63 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ceterix Orthopaedics, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$73.88 M (USD)
in 4 rounds
-
Latest Funding Round
$23.04 M (USD), Series C
Dec 19, 2016
-
Investors
SVB
& 6 more
-
Employee Count
63
as on Dec 31, 2018
-
Acquired by
Smith & Nephew
(Dec 18, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ceterix
Ceterix offers a comprehensive portfolio of products and services, including OxiSelect™ Assay Kits, Antibodies, Recombinant Proteins, and Cell Culture Reagents. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kits for measuring reactive oxygen species and lipid peroxidation
Antibodies for detecting proteins in biological samples
Proteins for cell biology and biochemistry research
Reagents to support cell growth and analysis
Unlock access to complete
Unlock access to complete
Leadership Team
48 people
Software Development Team
37 people
Senior Team
20 people
Sales and Marketing
14 people
Legal and Compliance
7 people
Operations Team
6 people
Finance and Accounting
5 people
Human Resources and Administration
5 people
Unlock access to complete
Funding Insights of Ceterix
Ceterix has successfully raised a total of $73.88M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $23.04 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $23.0M
-
First Round
First Round
(22 Jan 2013)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Series C - Ceterix | Valuation |
investors |
|
| May, 2015 | Amount | Debt – Conventional - Ceterix | Valuation |
investors |
|
| Apr, 2014 | Amount | Series B - Ceterix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ceterix
Ceterix has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Smith & Nephew and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRG is recognized as a premier healthcare investment partner.
|
Founded Year | Domain | Location | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
Venture capital fund backed incubator focused on the healthcare startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ceterix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ceterix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ceterix Comparisons
Competitors of Ceterix
Ceterix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SentreHEART, Tepha, SuturTek Incorporated, Planatome and Gordian Surgical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Suture-based devices for soft tissue closure are developed.
|
|
| domain | founded_year | HQ Location |
Absorbable biomaterials for medical sutures and meshes are developed.
|
|
| domain | founded_year | HQ Location |
Suturing devices are supplied for open and minimally invasive surgery.
|
|
| domain | founded_year | HQ Location |
Surgical scalpels and smart tools are developed for medical use.
|
|
| domain | founded_year | HQ Location |
Trocar with integrated closure system developed for laparoscopic procedures.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ceterix
Frequently Asked Questions about Ceterix
When was Ceterix founded?
Ceterix was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is Ceterix located?
Ceterix is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Ceterix a funded company?
Ceterix is a funded company, having raised a total of $73.88M across 4 funding rounds to date. The company's 1st funding round was a Series B of $31.34M, raised on Jan 22, 2013.
How many employees does Ceterix have?
As of Dec 31, 2018, the latest employee count at Ceterix is 63.
What does Ceterix do?
Ceterix Orthopaedics was founded in 2010 and is headquartered in Menlo Park, United States. Surgical tools for arthroscopic procedures in the orthopedic sector are developed by the company, with a focus on enabling stitches in tight joint spaces while safeguarding nerves, arteries, and cartilage. The NovoStitch suture passer is utilized for soft tissue suturing in hip and shoulder surgeries. FDA clearance for a suture cartridge was obtained in August 2018.
Who are the top competitors of Ceterix?
Ceterix's top competitors include Planatome, Gordian Surgical and Anchora Medical.
What products or services does Ceterix offer?
Ceterix offers OxiSelect™ Assay Kits, Antibodies, Recombinant Proteins, and Cell Culture Reagents.
Who are Ceterix's investors?
Ceterix has 7 investors. Key investors include SVB, Smith & Nephew, Oxford Finance, CRG, and Versant Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.